OVID Clinic Berlin (Compassionate Use)
Berlin, Germany
Treatment & access
- Treatments offeredPsilocybin
- Access routeCompassionate-use programme
- Pricing (published by the provider)No price published; psilocybin (PEX010) administered within authorised Expanded Access Programme; treatment embedded in multi-week day-clinic programme (day clinic ca. EUR 15,000 / 6 weeks, PKV usually covers): as published, checked 2026-08-05
- Compare with the country cost index →
- Phone+49 30 257 699 69 (Tagesklinik)
- Websitehttps://ovid-clinics.de
Languages spoken
As stated by the provider on its own website: each language links to the exact page and wording it was verified against.
Related listings
These records belong to the same organisation. They are listed separately because each is a distinct programme or location.
- Another programme at this clinicOVID Clinic Berlin : Ketamine / KAP
- Another programme at this clinicOVID Clinic Berlin (trial site) : Clinical trials
About this provider
Compassionate-use arm of OVID Clinics Berlin: under the direction of Prof. Dr. Gerhard Gruender, individual adult patients with treatment-resistant depression can receive psilocybin (PEX010, Filament Health) at the OVID day clinic in Berlin within Germany's first authorised Expanded Access (Compassionate Use) Programme, run jointly with the Central Institute of Mental Health (ZI) Mannheim since July 2025. It is not a regular therapy offer: eligibility requires a serious illness, no satisfactory approved treatment and no possibility of trial participation, with case-by-case benefit-risk review.
Services & programs
- Psilocybin single-dose treatment with accompanying psychotherapy (preparation and follow-up), within multi-week day-clinic setting
Programs & studies
| Program | Kind | Status |
|---|---|---|
| Psilocybin Expanded Access Programme for treatment-resistant depression (with ZI Mannheim; PEX010 / Filament Health) | active since 11 July 2025; exceptional cases only |
Facilities & languages
- Facilities
- OVID Tagesklinik, Boxhagener Str. 82, Berlin
- LanguagesGerman, English, Spanish, Turkish (clinic-wide)
- TeamProf. Dr. med. Gerhard Gruender (programme director, licence holder); Dr. med. Andrea Jungaberle (holds OVID's psilocybin treatment licence)
Common questions
Can I apply for psilocybin treatment?
Only in justified exceptional cases: adults with treatment-resistant depression, no satisfactory approved treatment available, and participation in a clinical trial not possible; each case undergoes benefit-risk review.
Is the programme a route to regular psilocybin therapy?
No. ZI/OVID state the Compassionate Use Programme cannot replace regulatory approval and that demand will significantly exceed capacity.
2 more verified providers within 50 km
- Teltow · 20 kmAsklepios Fachklinikum Brandenburg — Tagesklinik Teltow : Spravato®
- Werder (Havel) · 40 kmAsklepios Fachklinikum Brandenburg — Tagesklinik Werder : Spravato®
Verification
- License / registryBfArM confirmed Härtefallprogramm (compassionate use), psilocybin / treatment-resistant depression
- Official registryhttps://www.bfarm.de/DE/Arzneimittel/Klinische-Pruefung/Compassionate-Use/compUse-tabelle.html
- Independent sourcehttps://www.zi-mannheim.de/en/institute/news/compassionate-use-programm-fuer-psilocybin-erstmals-in-deutschland-moeglich.html
- Last verified
Check your fit & enquire
Check my fit & enquireWhat to prepare before you enquire
- A referral or the contact details of your treating clinician
- A list of medications you have tried (names, doses, duration)
- A short diagnosis summary or discharge letters